DrugPatentWatch Database Preview
Pharmacia Company Profile
What is the competitive landscape for PHARMACIA, and when can generic versions of PHARMACIA drugs launch?
There are eight US patents protecting PHARMACIA drugs.
There are two hundred and eighty-nine patent family members on PHARMACIA drugs in fifty-two countries and sixty supplementary protection certificates in twelve countries.
Summary for Pharmacia
| International Patents: | 289 |
| US Patents: | 8 |
| Tradenames: | 111 |
| Ingredients: | 86 |
| NDAs: | 136 |
| Patent Litigation for Pharmacia: | See patent lawsuits for Pharmacia |
Drugs and US Patents for Pharmacia
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | DEPO-ESTRADIOL | estradiol cypionate | INJECTABLE;INJECTION | 085470-003 | Approved Prior to Jan 1, 1982 | RX | No | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Pharmacia And Upjohn | DOXORUBICIN HYDROCHLORIDE | doxorubicin hydrochloride | INJECTABLE;INJECTION | 050467-003 | May 20, 1985 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Pharmacia And Upjohn | CORTISONE ACETATE | cortisone acetate | TABLET;ORAL | 008126-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | |||||
| Pharmacia And Upjohn | SOLU-CORTEF | hydrocortisone sodium succinate | INJECTABLE;INJECTION | 009866-003 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Pharmacia
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pharmacia And Upjohn | GENOTROPIN PRESERVATIVE FREE | somatropin recombinant | INJECTABLE;INJECTION | 020280-002 | Jan 27, 1998 | 5,716,338 | ➤ Sign Up |
| Pharmacia And Upjohn | GENOTROPIN PRESERVATIVE FREE | somatropin recombinant | INJECTABLE;INJECTION | 020280-001 | Jan 27, 1998 | 5,501,673 | ➤ Sign Up |
| Pharmacia And Upjohn | GLYNASE | glyburide | TABLET;ORAL | 020051-002 | Mar 4, 1992 | 3,507,954 | ➤ Sign Up |
| Pharmacia And Upjohn | DOSTINEX | cabergoline | TABLET;ORAL | 020664-001 | Dec 23, 1996 | 4,526,892 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for PHARMACIA drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 1 g | ➤ Subscribe | 2005-08-23 |
| ➤ Subscribe | Extended-release Capsules | 2 mg and 4 mg | ➤ Subscribe | 2007-07-30 |
| ➤ Subscribe | Injection | 2 mg/mL, 300 mL bag | ➤ Subscribe | 2009-09-01 |
| ➤ Subscribe | Tablets | 600 mg | ➤ Subscribe | 2005-12-21 |
| ➤ Subscribe | Oral Suspension | 100 mg/5 mL | ➤ Subscribe | 2009-08-03 |
| ➤ Subscribe | Injection | 2 mg/mL, 100 mL bag | ➤ Subscribe | 2009-12-29 |
Non-Orange Book US Patents for Pharmacia
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 6,444,813 | Linezolid-crystal form II | ➤ Sign Up |
| 7,008,637 | Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder | ➤ Sign Up |
| 6,517,864 | Transdermally administered tolterodine as anti-muscarinic agent for the treatment of overactive bladder | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Pharmacia Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Australia | 6737101 | ➤ Sign Up |
| Estonia | 200200631 | ➤ Sign Up |
| African Regional IP Organization (ARIPO) | 1529 | ➤ Sign Up |
| Iceland | 2370 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Pharmacia Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| /1997 | Austria | ➤ Sign Up | PRODUCT NAME: LATANOPROST UND SEINE THERAPEUTISCH AKTIVEN UND PHYSIOLOGISCH ANNEHMBAREN DERIVATE; NAT. REGISTRATION NO/DATE: 1-22019 19970627; FIRST REGISTRATION: SE 12716 19960718 |
| 401 | Luxembourg | ➤ Sign Up | PRODUCT NAME: CLINDAMYCINE(EN TANT QUE PHOPSHATE DE CLINDAMYCINE)ET TRETINOINE |
| C/GB05/047 | United Kingdom | ➤ Sign Up | PRODUCT NAME: PEGVISOMANT, OPTIONALLY IN THE FORM OF A PEGYLATION VARIANT; REGISTRATION NO/DATE: EU/1/02/240/001 - 003 20021113 |
| C0022 | France | ➤ Sign Up | PRODUCT NAME: ESTRADIOL ANHYDRE DROSPIRENONE; REGISTRATION NO/DATE IN FRANCE: NL 28661 DU 20040316; REGISTRATION NO/DATE AT EEC: RVG 27505 DU 20021211 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
